Literature DB >> 23420891

Cutting edge: cell-autonomous control of IL-7 response revealed in a novel stage of precursor B cells.

Gabriel J Sandoval1, Daniel B Graham, Deepta Bhattacharya, Barry P Sleckman, Ramnik J Xavier, Wojciech Swat.   

Abstract

During early stages of B-lineage differentiation in bone marrow, signals emanating from IL-7R and pre-BCR are thought to synergistically induce proliferative expansion of progenitor cells. Paradoxically, loss of pre-BCR-signaling components is associated with leukemia in both mice and humans. Exactly how progenitor B cells perform the task of balancing proliferative burst dependent on IL-7 with the termination of IL-7 signals and the initiation of L chain gene rearrangement remains to be elucidated. In this article, we provide genetic and functional evidence that the cessation of the IL-7 response of pre-B cells is controlled via a cell-autonomous mechanism that operates at a discrete developmental transition inside Fraction C' (large pre-BII) marked by transient expression of c-Myc. Our data indicate that pre-BCR cooperates with IL-7R in expanding the pre-B cell pool, but it is also critical to control the differentiation program shutting off the c-Myc gene in large pre-B cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23420891      PMCID: PMC3649847          DOI: 10.4049/jimmunol.1203208

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Pre-BCR signals and the control of Ig gene rearrangements.

Authors:  Jamie K Geier; Mark S Schlissel
Journal:  Semin Immunol       Date:  2006-01-18       Impact factor: 11.130

Review 2.  Dual role of the adaptor protein SLP-65: organizer of signal transduction and tumor suppressor of pre-B cell leukemia.

Authors:  Sebastian Herzog; Bettina Storch; Hassan Jumaa
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  IL-7: a key regulator of B lymphopoiesis.

Authors:  Craig D Milne; Christopher J Paige
Journal:  Semin Immunol       Date:  2005-11-21       Impact factor: 11.130

Review 4.  Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells.

Authors:  Rudi W Hendriks; Rogier Kersseboom
Journal:  Semin Immunol       Date:  2005-11-21       Impact factor: 11.130

5.  A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation.

Authors:  Kyoko Ochiai; Mark Maienschein-Cline; Malay Mandal; Joseph R Triggs; Eric Bertolino; Roger Sciammas; Aaron R Dinner; Marcus R Clark; Harinder Singh
Journal:  Nat Immunol       Date:  2012-01-22       Impact factor: 25.606

6.  Analysis of C-MYC function in normal cells via conditional gene-targeted mutation.

Authors:  I M de Alboran; R C O'Hagan; F Gärtner; B Malynn; L Davidson; R Rickert; K Rajewsky; R A DePinho; F W Alt
Journal:  Immunity       Date:  2001-01       Impact factor: 31.745

7.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

Authors:  K Kelly; B H Cochran; C D Stiles; P Leder
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

8.  c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL.

Authors:  Kirsteen H Maclean; Ulrich B Keller; Carlos Rodriguez-Galindo; Jonas A Nilsson; John L Cleveland
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.

Authors:  Hassan Jumaa; Lukas Bossaller; Karina Portugal; Bettina Storch; Michael Lotz; Alexandra Flemming; Martin Schrappe; Ville Postila; Pekka Riikonen; Jukka Pelkonen; Charlotte M Niemeyer; Michael Reth
Journal:  Nature       Date:  2003-05-22       Impact factor: 49.962

10.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.

Authors:  J J Peschon; P J Morrissey; K H Grabstein; F J Ramsdell; E Maraskovsky; B C Gliniak; L S Park; S F Ziegler; D E Williams; C B Ware; J D Meyer; B L Davison
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more
  6 in total

1.  Early B-cell factor 1 regulates the expansion of B-cell progenitors in a dose-dependent manner.

Authors:  Josefine Åhsberg; Jonas Ungerbäck; Tobias Strid; Eva Welinder; Jenny Stjernberg; Malin Larsson; Hong Qian; Mikael Sigvardsson
Journal:  J Biol Chem       Date:  2013-09-27       Impact factor: 5.157

2.  Novel mechanism of tumor suppression by polarity gene discs large 1 (DLG1) revealed in a murine model of pediatric B-ALL.

Authors:  Gabriel J Sandoval; Daniel B Graham; Grzegorz B Gmyrek; Holly M Akilesh; Keiko Fujikawa; Benedicte Sammut; Deepta Bhattacharya; Shuba Srivatsan; Alfred Kim; Andrey S Shaw; Katherine Yang-Iott; Craig H Bassing; Eric Duncavage; Ramnik J Xavier; Wojciech Swat
Journal:  Cancer Immunol Res       Date:  2013-10-07       Impact factor: 11.151

Review 3.  Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling.

Authors:  Marcus R Clark; Malay Mandal; Kyoko Ochiai; Harinder Singh
Journal:  Nat Rev Immunol       Date:  2013-12-31       Impact factor: 53.106

Review 4.  Balancing Proliferation with Igκ Recombination during B-lymphopoiesis.

Authors:  Keith M Hamel; Malay Mandal; Sophiya Karki; Marcus R Clark
Journal:  Front Immunol       Date:  2014-04-02       Impact factor: 7.561

5.  The c-Myc/miR17-92/PTEN Axis Tunes PI3K Activity to Control Expression of Recombination Activating Genes in Early B Cell Development.

Authors:  David Benhamou; Verena Labi; Andrew Getahun; Eli Benchetrit; Reem Dowery; Klaus Rajewsky; John C Cambier; Doron Melamed
Journal:  Front Immunol       Date:  2018-11-22       Impact factor: 7.561

6.  Discrete roles and bifurcation of PTEN signaling and mTORC1-mediated anabolic metabolism underlie IL-7-driven B lymphopoiesis.

Authors:  Hu Zeng; Mei Yu; Haiyan Tan; Yuxin Li; Wei Su; Hao Shi; Yogesh Dhungana; Cliff Guy; Geoffrey Neale; Caryn Cloer; Junmin Peng; Demin Wang; Hongbo Chi
Journal:  Sci Adv       Date:  2018-01-31       Impact factor: 14.957

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.